Cargando…
mTOR Regulation of Metabolism in Hematologic Malignancies
Neoplastic cells rewire their metabolism, acquiring a selective advantage over normal cells and a protection from therapeutic agents. The mammalian Target of Rapamycin (mTOR) is a serine/threonine kinase involved in a variety of cellular activities, including the control of metabolic processes. mTOR...
Autores principales: | Mirabilii, Simone, Ricciardi, Maria Rosaria, Tafuri, Agostino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072383/ https://www.ncbi.nlm.nih.gov/pubmed/32053876 http://dx.doi.org/10.3390/cells9020404 |
Ejemplares similares
-
Biological Aspects of mTOR in Leukemia
por: Mirabilii, Simone, et al.
Publicado: (2018) -
Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia
por: Iacovelli, Stefano, et al.
Publicado: (2015) -
Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies
por: Tasian, Sarah K., et al.
Publicado: (2014) -
mTOR and lysosome regulation
por: Puertollano, Rosa
Publicado: (2014) -
mTOR Regulation of Glycolytic Metabolism in T Cells
por: Salmond, Robert J.
Publicado: (2018)